Search

everythinglearnresearchcommunity

for

Search:↓

DHT, a testosterone byproduct, causes male pattern baldness.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Quercetin may help with PCOS symptoms, but more research is needed.

Low testosterone may indicate severe COVID-19 in men.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

New compounds may soon be tested to treat excessive hair growth in women.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Both types of oral contraceptives improved symptoms and hormone levels in women with PCOS.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.